We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCH
1501
Dauch Corp
DCH
$1.35B
$44K ﹤0.01%
+2,316
New +$39.2K
CLDX icon
1502
Celldex Therapeutics
CLDX
$3.26B
$44K ﹤0.01%
813
+732
+904% +$41.6K
CMPR icon
1503
Cimpress
CMPR
$2.34B
$44K ﹤0.01%
487
+186
+62% +$16.9K
G icon
1504
Genpact
G
$6.13B
$44K ﹤0.01%
1,835
-60
-3% -$1.43K
HHS icon
1505
Harte-Hanks
HHS
$16.9M
$44K ﹤0.01%
2,933
+1,273
+77% +$19.3K
MOG.A icon
1506
Moog Inc Class A
MOG.A
$13B
$44K ﹤0.01%
+675
New +$43K
PBI icon
1507
Pitney Bowes
PBI
$2.46B
$44K ﹤0.01%
2,891
+2,415
+507% +$38.4K
PRA
1508
DELISTED
ProAssurance
PRA
$44K ﹤0.01%
+781
New +$43.3K
PRK icon
1509
Park National Corp
PRK
$3.71B
$44K ﹤0.01%
367
+297
+424% +$31.7K
RDUS
1510
DELISTED
Radius Recycling
RDUS
$44K ﹤0.01%
1,712
+168
+11% +$4.32K
SHOE
1511
Shoe Station Group
SHOE
$425M
$44K ﹤0.01%
+3,234
New +$44.3K
SEDG icon
1512
SolarEdge
SEDG
$1.99B
$44K ﹤0.01%
3,531
+3,131
+783% +$43.5K
SYNA icon
1513
Synaptics
SYNA
$3.99B
$44K ﹤0.01%
821
+218
+36% +$12.6K
TCX icon
1514
Tucows
TCX
$157M
$44K ﹤0.01%
929
+869
+1,448% +$28.1K
THS
1515
DELISTED
Treehouse Foods
THS
$44K ﹤0.01%
611
-2,933
-83% -$224K
TOL icon
1516
Toll Brothers
TOL
$14.1B
$44K ﹤0.01%
1,413
-10,474
-88% -$310K
VYX icon
1517
NCR Voyix
VYX
$1.15B
$44K ﹤0.01%
1,773
-8,141
-82% -$183K
LOGM
1518
DELISTED
LogMein, Inc.
LOGM
$44K ﹤0.01%
+460
New +$44.7K
GNC
1519
DELISTED
GNC Holdings, Inc.
GNC
$44K ﹤0.01%
4,012
+1,705
+74% +$26.7K
EVHC
1520
DELISTED
Envision Healthcare Holdings Inc
EVHC
$44K ﹤0.01%
685
+578
+540% +$37.8K
OAKS
1521
DELISTED
Five Oaks Investment Corp.
OAKS
$44K ﹤0.01%
8,819
+5,758
+188% +$30.4K
TERP
1522
DELISTED
TerraForm Power, Inc
TERP
$44K ﹤0.01%
+3,481
New +$45.3K
MACK
1523
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$44K ﹤0.01%
+1,358
New +$57.9K
ADNT icon
1524
Adient
ADNT
$1.48B
$43K ﹤0.01%
+730
New +$38.5K
AWR icon
1525
American States Water
AWR
$3.36B
$43K ﹤0.01%
+945
New +$39.4K
59 60
61
62 63

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.